Dr. Behfar Ehdaie

So almost one out of 12 men getting a radical prostatectomy and go on to get a secondary surgery due to our intervention. So we asked the simple question, can we improve that? Well, the literature provides some guidance. So we knew the question was important to reduce even 30%.

So almost one out of 12 men getting a radical prostatectomy and go on to get a secondary surgery due to our intervention. So we asked the simple question, can we improve that? Well, the literature provides some guidance. So we knew the question was important to reduce even 30%.

That number would be a significant improvement in patients' lives, a quality of life, cost to the healthcare system, burden of treatment for patients. And there was data to suggest A is standard of care and B is standard of care. We just didn't know which one was better. So we launched the concept, let's go ahead and do a cluster randomized trial.

That number would be a significant improvement in patients' lives, a quality of life, cost to the healthcare system, burden of treatment for patients. And there was data to suggest A is standard of care and B is standard of care. We just didn't know which one was better. So we launched the concept, let's go ahead and do a cluster randomized trial.

That number would be a significant improvement in patients' lives, a quality of life, cost to the healthcare system, burden of treatment for patients. And there was data to suggest A is standard of care and B is standard of care. We just didn't know which one was better. So we launched the concept, let's go ahead and do a cluster randomized trial.

We already assessed hernia after surgery at both the six-week follow-up, six-month follow-up, and one-year follow-up as part of our notes and systematic approach to seeing patients. So why not up front? tell surgeons that we randomize every three months to say, now close your incision vertically or close your incisions horizontally.

We already assessed hernia after surgery at both the six-week follow-up, six-month follow-up, and one-year follow-up as part of our notes and systematic approach to seeing patients. So why not up front? tell surgeons that we randomize every three months to say, now close your incision vertically or close your incisions horizontally.

We already assessed hernia after surgery at both the six-week follow-up, six-month follow-up, and one-year follow-up as part of our notes and systematic approach to seeing patients. So why not up front? tell surgeons that we randomize every three months to say, now close your incision vertically or close your incisions horizontally.

This is not an earth shattering study that will change the future of prostate cancer. But because it's not, it can't be an expensive trial. It can't be a burden on surgeons. It can't be a burden on the healthcare system or patients. So it's these small questions that are still important and can direct our clinical management can be answered if it's already integrated in our healthcare system.

This is not an earth shattering study that will change the future of prostate cancer. But because it's not, it can't be an expensive trial. It can't be a burden on surgeons. It can't be a burden on the healthcare system or patients. So it's these small questions that are still important and can direct our clinical management can be answered if it's already integrated in our healthcare system.

This is not an earth shattering study that will change the future of prostate cancer. But because it's not, it can't be an expensive trial. It can't be a burden on surgeons. It can't be a burden on the healthcare system or patients. So it's these small questions that are still important and can direct our clinical management can be answered if it's already integrated in our healthcare system.

So in this study, all we needed to do was we had the outcome measure already measured. We had patients eligibility criteria based on who we take to radical prostatectomy. All surgeons were on board. And so we would randomize a surgeon every three months to do it one way or the other. And if they deviated,

So in this study, all we needed to do was we had the outcome measure already measured. We had patients eligibility criteria based on who we take to radical prostatectomy. All surgeons were on board. And so we would randomize a surgeon every three months to do it one way or the other. And if they deviated,

So in this study, all we needed to do was we had the outcome measure already measured. We had patients eligibility criteria based on who we take to radical prostatectomy. All surgeons were on board. And so we would randomize a surgeon every three months to do it one way or the other. And if they deviated,

because they felt the patient needed to do it one way for some clinical reason that they had that we didn't want to adjust, they would just record that. Say I was, for example, randomized to vertical, but I did horizontal enclosure for this patient for XYZ reason. And that's why in our consents with patients, we always state, we don't know what's better. That's why we do these studies.

because they felt the patient needed to do it one way for some clinical reason that they had that we didn't want to adjust, they would just record that. Say I was, for example, randomized to vertical, but I did horizontal enclosure for this patient for XYZ reason. And that's why in our consents with patients, we always state, we don't know what's better. That's why we do these studies.

because they felt the patient needed to do it one way for some clinical reason that they had that we didn't want to adjust, they would just record that. Say I was, for example, randomized to vertical, but I did horizontal enclosure for this patient for XYZ reason. And that's why in our consents with patients, we always state, we don't know what's better. That's why we do these studies.

But in the operating room, this trial that you're signing up to will not alter what a surgeon does to you if they think one way is better than the other. All we're doing is asking for your permission to collect data to determine if the intervention made an impact. And so that trial enrolled over 1,400 patients over a three-year period, but was interesting.

But in the operating room, this trial that you're signing up to will not alter what a surgeon does to you if they think one way is better than the other. All we're doing is asking for your permission to collect data to determine if the intervention made an impact. And so that trial enrolled over 1,400 patients over a three-year period, but was interesting.

But in the operating room, this trial that you're signing up to will not alter what a surgeon does to you if they think one way is better than the other. All we're doing is asking for your permission to collect data to determine if the intervention made an impact. And so that trial enrolled over 1,400 patients over a three-year period, but was interesting.